Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA

被引:16
作者
Costa, SL
McBurney, MW
机构
[1] OTTAWA REG CANC CTR,DEPT BIOCHEM,OTTAWA,ON K1H 8L6,CANADA
[2] UNIV OTTAWA,DEPT MED,OTTAWA,ON K1H 8L6,CANADA
关键词
D O I
10.1006/excr.1996.0154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Retinoic acid (RA) is a potent inducer of P19 cell differentiation. RA activity is thought to be mediated by nuclear RA receptors (RARs), transcription factors whose activity is dependent on RA. There are three RARs called alpha, beta, and gamma. We created truncated versions of the three RARs and compared their activities as inhibitors of RA-mediated gene transcription and of P19 cell differentiation. Only mutants of the RAR alpha were inhibitory in these assays. A mutant of RAR alpha carrying a 10-amino-acid insert was able to heterodimerize with RXR beta or with the normal RAR alpha and the inhibitory activity of this mutant was dependent on an intact DNA binding domain. We conclude that dominant negative mutants of RAR alpha act by heterodimerizing with RXRs or RARs and binding to RA response elements on DNA, thereby preventing binding of the normal receptors to those sites. (C) 1996 Academic Press, Inc.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 59 条
[1]   CLONING AND EXPRESSION OF THE MOUSE PGK-1 GENE AND THE NUCLEOTIDE-SEQUENCE OF ITS PROMOTER [J].
ADRA, CN ;
BOER, PH ;
MCBURNEY, MW .
GENE, 1987, 60 (01) :65-74
[2]   IDENTIFICATION OF HUMAN, MOUSE, AND RAT RETINOIC ACID RECEPTOR-ALPHA USING MONOCLONAL-ANTIBODIES [J].
ALI, M ;
TORIAN, BE ;
VEDECKIS, WV .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) :1032-1039
[3]  
AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
[4]   THE CONSERVED 9TH C-TERMINAL HEPTAD IN THYROID-HORMONE AND RETINOIC ACID RECEPTORS MEDIATES DIVERSE RESPONSES BY AFFECTING HETERODIMER BUT NOT HOMODIMER FORMATION [J].
AUFLIEGNER, M ;
HELMER, E ;
CASANOVA, J ;
RAAKA, BM ;
SAMUELS, HH .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (09) :5725-5737
[5]   THE TAU-4 ACTIVATION DOMAIN OF THE THYROID-HORMONE RECEPTOR IS REQUIRED FOR RELEASE OF A PUTATIVE COREPRESSOR(S) NECESSARY FOR TRANSCRIPTIONAL SILENCING [J].
BANIAHMAD, A ;
LENG, XH ;
BURRIS, TP ;
TSAI, SY ;
TSAI, MJ ;
OMALLEY, BW .
MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) :76-86
[6]   CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR [J].
BARETTINO, D ;
RUIZ, MDMV ;
STUNNENBERG, HG .
EMBO JOURNAL, 1994, 13 (13) :3039-3049
[7]   UNLIGANDED T3R, BUT NOT ITS ONCOGENIC VARIANT, V-ERBA, SUPPRESSES RAR-DEPENDENT TRANSACTIVATION BY TITRATING OUT RXR [J].
BARETTINO, D ;
BUGGE, TH ;
BARTUNEK, P ;
RUIZ, MDMV ;
SONNTAGBUCK, V ;
BEUG, H ;
ZENKE, M ;
STUNNENBERG, HG .
EMBO JOURNAL, 1993, 12 (04) :1343-1354
[8]   A NEW RETINOIC ACID RECEPTOR IDENTIFIED FROM A HEPATOCELLULAR-CARCINOMA [J].
BENBROOK, D ;
LERNHARDT, E ;
PFAHL, M .
NATURE, 1988, 333 (6174) :669-672
[9]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[10]   RXR-ALPHA, A PROMISCUOUS PARTNER OF RETINOIC ACID AND THYROID-HORMONE RECEPTORS [J].
BUGGE, TH ;
POHL, J ;
LONNOY, O ;
STUNNENBERG, HG .
EMBO JOURNAL, 1992, 11 (04) :1409-1418